xFOREST Therapeutics
$6.0M
Funding date
Valuation / Funding
No funding history available
Funding data has not been imported for this company yet
Current Valuation Metrics
xFOREST Therapeutics is currently valued at $53.5M as of January 24, 2025. The company has raised a total of $7.3M in funding.
Capital Efficiency
With a capital efficiency ratio of 7.32x, xFOREST Therapeutics has achieved a valuation that is 7.32 times the total capital raised. This metric indicates strong capital efficiency and effective deployment of investor funds.
Investment Perspective
xFOREST Therapeutics's valuation reflects investor confidence in the company's market position, growth potential, and ability to execute on its business model. Private market valuations are determined by primary funding rounds and secondary market transactions, which take into account financial performance, market conditions, and growth prospects.
What is xFOREST Therapeutics Worth in 2025?
As of 2025, xFOREST Therapeutics is valued at $53.5M, based on the company's Later Stage VC funding round in January 24, 2025. This valuation positions xFOREST Therapeutics as one of the leading private companies in the sector.
xFOREST Therapeutics Valuation History
xFOREST Therapeutics's funding history demonstrates steady growth and investor confidence.
How xFOREST Therapeutics Valuation is Determined
Private company valuations like xFOREST Therapeutics's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including:
- Revenue growth and financial performance
- Market opportunity and total addressable market (TAM)
- Competitive positioning and market share
- Management team strength and execution capability
- Technology and intellectual property
- Industry trends and investor sentiment
xFOREST Therapeutics Valuation FAQs
Is xFOREST Therapeutics profitable?
xFOREST Therapeutics has not publicly disclosed its profitability status. Many high-growth private companies prioritize market expansion and user growth over profitability in their early stages.
How does xFOREST Therapeutics's valuation compare to competitors?
xFOREST Therapeutics is valued at $53.5M, positioning it as a major player in the space. Secondary market pricing and private market transactions provide ongoing validation of this valuation.
When will xFOREST Therapeutics IPO?
xFOREST Therapeutics has not announced plans for an initial public offering. Until an IPO, investors can access xFOREST Therapeutics shares through secondary market platforms.